KKR buys stake in Malaysia's Avisena in healthcare push

KKR, the global investment firm, has announced plans to acquire a minority stake in Malaysia's Avisena Healthcare, expanding its presence in the Southeast Asian healthcare sector. This move comes as investor interest in the region's healthcare assets continues to grow, driven by factors such as rising incomes, aging populations, and increased demand for private medical treatment.

KKR's involvement is expected to fuel Avisena's upcoming expansion plans, which include the development of new multi-specialty hospitals at its existing locations in Shah Alam and the construction of additional greenfield hospitals within the Klang Valley. The firm has not disclosed the exact terms of the investment, including the percentage stake and the total investment amount.

In a related development, Reuters had previously reported that KKR was a leading candidate to purchase a controlling interest of up to 25 percent in Avisena, with a potential deal value ranging from RM300 million to RM400 million. KKR's existing healthcare investments in the Asia Pacific region include Medical Saigon Group in Vietnam, Metro Pacific Hospital in the Philippines, and Topcon Corp in Japan.